Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Change in Account Payables (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Change in Account Payables readings, the most recent being -$30000.0 for Q2 2025.

  • On a quarterly basis, Change in Account Payables fell 700.0% to -$30000.0 in Q2 2025 year-over-year; TTM through Dec 2025 was -$30000.0, a 3.45% decrease, with the full-year FY2025 number at -$30000.0, down 3.45% from a year prior.
  • Change in Account Payables hit -$30000.0 in Q2 2025 for Arcadia Biosciences, up from -$51000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $18000.0 in Q3 2021 to a low of -$54000.0 in Q1 2021.
  • Median Change in Account Payables over the past 5 years was $6000.0 (2021), compared with a mean of -$5062.5.
  • The widest YoY moves for Change in Account Payables: up 1100.0% in 2023, down 760.0% in 2023.
  • Arcadia Biosciences' Change in Account Payables stood at $13000.0 in 2021, then crashed by 92.31% to $1000.0 in 2022, then surged by 1100.0% to $12000.0 in 2023, then plummeted by 525.0% to -$51000.0 in 2024, then surged by 41.18% to -$30000.0 in 2025.
  • The last three reported values for Change in Account Payables were -$30000.0 (Q2 2025), -$51000.0 (Q3 2024), and $5000.0 (Q2 2024) per Business Quant data.